Treatment nonexistent for some glioblastoma patients

September 13, 2017

Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.

The study, which is one of the largest on and outcomes, also shows that patients treated at high-volume centers live approximately three and one-half months longer than patients treated at low-volume centers.

Dr. Matthew Koshy, corresponding author on the paper, says this difference in outcomes is on par with results seen in phase III clinical trials—the last of which for glioblastoma was two years ago.

"It has been very difficult to find new treatments for glioblastoma, and there has been little progress toward improving outcomes for patients suffering from this type of cancer," said Koshy, radiation oncologist at the University of Illinois Hospital & Health Sciences System. "To see a significant difference in outcomes, based solely on type of facility, offers strong and, more importantly, actionable evidence that physicians and patients can use today as they consider treatment options."

While the researchers say it is not surprising to see better outcomes for patients treated at high-volume centers—where there are more likely to be robust clinical trial and multidisciplinary programs—it is surprising to see that patients treated at low and medium-volume facilities were less likely to even receive treatment.

Standard treatment for glioblastoma, which is a common and highly malignant type of brain , includes surgery followed by radiation and chemotherapy. The researchers hypothesized that physicians at low and medium-volume centers, which make up the vast majority of centers, may hesitate to recommend treatment due to the historically poor prognosis associated with glioblastoma and a lack of resources for dealing with complex cases.

"This study suggests that patients newly diagnosed with glioblastoma benefit from care at a hospital that treats a high number of patients with brain tumors," Koshy said, "and that most physicians should consider referring glioblastoma patients to high-volume or before advising against treatment."

Using data from the National Cancer Data Base (NCDB), a combined registry of the American Cancer Society and the American College of Surgeons' Commission on Cancer (CoC), the study included 68,726 diagnosed with glioblastomas between 2006 and 2013. Hospital volume was determined based on the average number of glioblastoma cases per year. Low-volume centers saw less than nine cases; medium-volume centers saw nine to 23 cases per year; and high-volume centers saw more than 23 cases per year.

The findings are published in the Journal of Neuro-Oncology.

Explore further: Center surgical volume linked to LVAD patient outcomes

More information: Matthew Koshy et al, Association between hospital volume and receipt of treatment and survival in patients with glioblastoma, Journal of Neuro-Oncology (2017). DOI: 10.1007/s11060-017-2598-2

Related Stories

Center surgical volume linked to LVAD patient outcomes

September 8, 2017
(HealthDay)—Center surgical volume is associated with left ventricular assist device (LVAD) patient outcomes, with worse survival at very-low-volume centers, according to a study published online Sept. 6 in JACC: Heart ...

Survival correlation for low versus high enrolling institutions for patients with LA-NSCLC

June 7, 2016
Lung cancer is the leading cause of cancer-related death in the United States and is estimated to have contributed to 221,200 new cases and 158,040 deaths in 2015 alone. A secondary analysis of NRG Oncology's clinical trial ...

Identification of PTPRZ as a drug target for cancer stem cells in glioblastoma

July 19, 2017
Glioblastoma is a malignant brain tumor with high mortality. Cancer stem cells are thought to be crucial for tumor initiation and its recurrence after standard therapy with radiation and temozolomide (TMZ) chemotherapy. Protein ...

Link between facility volume and radiation outcomes for head and neck cancers

September 27, 2016
The association between provider case volume and outcomes has long been suggested in cancer care. A Yale Cancer Center team has completed a review of outcomes for patients with locally advanced squamous cell head and neck ...

Cervical cancer patients more likely to survive if treated at high-volume medical facilities

March 12, 2013
Patients with locally advanced cervical cancer have better treatment outcomes and are more likely to survive the disease if they receive care at a high-volume medical center than patients treated at low-volume facilities, ...

Study shows that choice of medical center impacts life expectancy of multiple myeloma patients

October 26, 2016
People diagnosed with multiple myeloma are more likely to live longer if they are treated at a medical center that sees many patients with this blood cancer. Mayo Clinic researchers published these findings today in the Journal ...

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.